ClinicalTrials.Veeva

Menu

Termination of Persistent Atrial Fibrillation by Catheter Ablation

Shanghai Jiao Tong University logo

Shanghai Jiao Tong University

Status

Unknown

Conditions

Atrial Fibrillation

Treatments

Procedure: Catheter ablation

Study type

Observational

Funder types

Other

Identifiers

NCT04958928
Termination-AF

Details and patient eligibility

About

This is a prospective, multicenter, cohort study aims to demonstrate the role of termination of AF in ablation for persistent atrial fibrillation, and evaluate the clinical outcomes in patients with or without AF termination.

Enrollment

400 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Aged 18 to 80 years old; 2. Persistent AF; 3. Nonresponse or intolerance to ≥1 antiarrhythmic drug.

Exclusion criteria

  1. With uncontrolled congestive heart failure;

  2. Having significant valvular disease and/or prosthetic heart valve(s);

  3. With myocardial infarction or stroke within 6 months of screening;

  4. With Significant congenital heart disease;

  5. Ejection fraction was <40% measured by echocardiography;

  6. Allergic to contrast media;

  7. Contraindication to anticoagulation medications;

  8. Severe pulmonary disease e.g. restrictive pulmonary disease, chronic obstructive disease (COPD);

  9. Left atrial (LA) thrombus measured by pre-procedure transesophageal echocardiography;

  10. Having any contraindication to right or left sided heart catheterization; 11. Previous atrial fibrillation ablation;

  11. Presence of an implanted cardioverter-defibrillator; 13. Any cardiac surgery within the past 2 months; 14. Poor general health; 15.Life expectancy less than 6 months.

Trial design

400 participants in 1 patient group

Persistent AF Group
Treatment:
Procedure: Catheter ablation

Trial contacts and locations

0

Loading...

Central trial contact

Qin Mu, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems